EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Nanomicelles: Utilizing Peptide Transporters to Overcome Corneal Barrier for Treating Fungal Infection

Priyadarshini Sathe, Vasagiri Nagarjuna, Hanuman Sharma, Thirumurthy Velpandian, Prashant Garg, Jayabalan Nirmal iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Priyadarshini Sathe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Translational Pharmaceutics Research Laboratory (TPRL), Department of Pharmacy, Birla Institute of Technology and Sciences, Pilani, Hyderabad Campus,…. Hauptthemen laut MEDLINE: Antifungal Agents, Cornea, Nanoparticles, Biomimetic Materials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The corneal barrier restricts the entry of xenobiotics (including drugs) in the anterior segment of the eye, resulting in less than 5% of the drug reaching the target site (deep corneal tissues) - necessitating frequent topical eye drop administration. Interestingly, despite these barriers, endogenous peptides are shuttled across the cornea by peptide transporters expressed on the corneal epithelium. The current study investigates the potential of targeting peptide transporters to increase the permeability of poorly permeable drugs across the cornea. D-α-tocopherol polyethylene glycol succinate (TPGS), an amphiphilic polymer, was conjugated with Glycyl-Sarcosine (Gly-Sar), a well-known peptide transporter ligand to develop nanomicelles. Natamycin, a poorly water-soluble and poorly permeable drug, was entrapped (0.6%) in Gly-Sar-TPGS-formulated nanomicelles. Both ex vivo and in vivo studies demonstrated that the natamycin-loaded Gly-Sar-TPGS nanomicelles (PeNatcel) enhanced permeation across the cornea. The PeNatcel demonstrated therapeutic efficiency against Candida albicans and Aspergillus flavus using in vitro and ex vivo antifungal studies. PeNatcel showed comparable activity against Candida albicans at 4 times a day dosing frequency compared to 12 times a day marketed 5% natamycin suspension. Consequently, the developed peptide transporter-specific ligand-conjugated nanomicelles delivery system can also be explored further for other water-insoluble and poorly permeable drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCorneaNanoparticlesBiomimetic MaterialsAnimalsMicellesCandida albicansNatamycinAspergillus flavusVitamin EBiomimeticsPermeabilityEpithelium, CornealDrug Delivery SystemsPeptidesRabbitsHumans

Stichwörter der Autor:innen

NanomicellesNatamycinOcular drug deliveryPeptide transporterTransporter targeted delivery

Substanzen

MicellesAntifungal AgentsNatamycintocophersolanVitamin EPeptides

Autor:innen und Institutionen

  • Translational Pharmaceutics Research Laboratory (TPRL), Department of Pharmacy, Birla Institute of Technology and Sciences, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Telangana 500078, Indi…
  • Shantilal Shanghvi Cornea Institute, KAR Campus, LV Prasad Eye Institute, Hyderabad 500034, Telangana, India.
  • Bioanalytics Facility, Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi 110029, India.
  • Department of Ocular Pharmacology & Pharmacy, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi 110029, India.
  • Centre for Ocular Drug Delivery Devices (CODDD), Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Jawahar Nagar, Kapra Mandal, Medchal District, Telangana 500078, India.

ORCID-Profile: Jayabalan Nirmal

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Sathe, P., Nagarjuna, V., Sharma, H., Velpandian, T., Garg, P., & Nirmal, J. (2025). Biomimetic Nanomicelles: Utilizing Peptide Transporters to Overcome Corneal Barrier for Treating Fungal Infection. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00423

Vancouver

Sathe P, Nagarjuna V, Sharma H, Velpandian T, Garg P, Nirmal J. Biomimetic Nanomicelles: Utilizing Peptide Transporters to Overcome Corneal Barrier for Treating Fungal Infection. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00423

BibTeX
@article{Sathe2025,
  author = {Sathe, Priyadarshini and Nagarjuna, Vasagiri and Sharma, Hanuman and Velpandian, Thirumurthy and Garg, Prashant and Nirmal, Jayabalan},
  title = {Biomimetic Nanomicelles: Utilizing Peptide Transporters to Overcome Corneal Barrier for Treating Fungal Infection},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00423}
}
Kostenlos starten →